Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim with Weekly Paclitaxel/Carboplatin in Gynaecological Cancers
NCT01523678Phase 2Completed
- Sponsor
- Belgian Gynaecological Oncology Group
- Start
- Feb 2012
- Primary completion
- May 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), endometrial cancer (EC), Cervical Cancer (CC), sponsored by Belgian Gynaecological Oncology Group. Started Feb 2012; status: completed.
02
Drugs
filgrastim
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)endometrial cancer (EC)Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01523678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01523678.